Targeted Therapy Technologies, LLC
Irvine, CA
- UEI
- SF8GTWW4GDY5
- CAGE
- 4G0F1
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 16 Technology Dr #134, Irvine, CA 92618, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Retinoblastoma phase II expanded access clinical trial - abstract retinoblastoma (RB) is a micro-orphan disease… | FDA Office of Acquisition and Grant Services | $1,300,000 | |
| Phase i clinical investigation of episcleral topotecan in retinoblastoma | FDA Office of Acquisition and Grant Services | $1,258,599 | |
| Episcleral COX-2 and steroid agents as comprehensive therapeutic interventions | Department of Defense | $999,917 | |
| Episcleral tharapy for IED-related ophthalmic injury | Department of Defense | $2,661,000 | |
| Episcleral chemotherapy as salvage therapy for eyes with retinoblastoma | National Institutes of Health | $2,769,464 |
Quick answers
What is Targeted Therapy Technologies, LLC's UEI?
Targeted Therapy Technologies, LLC's Unique Entity ID (UEI) in SAM.gov is SF8GTWW4GDY5.
What is Targeted Therapy Technologies, LLC's CAGE code?
Targeted Therapy Technologies, LLC's CAGE code is 4G0F1.
What is Targeted Therapy Technologies, LLC's primary NAICS code?
Targeted Therapy Technologies, LLC's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Targeted Therapy Technologies, LLC located?
Targeted Therapy Technologies, LLC's physical address in SAM.gov is 16 Technology Dr #134, Irvine, CA 92618, USA.
Is Targeted Therapy Technologies, LLC registered in SAM.gov?
Yes. Targeted Therapy Technologies, LLC's SAM.gov registration is active through December 2, 2026.
What is Targeted Therapy Technologies, LLC's most recent federal award?
Targeted Therapy Technologies, LLC's most recent federal grant award is Retinoblastoma phase II expanded access clinical trial - abstract retinoblastoma (RB) is a micro-orphan disease… (R01FD008443), from FDA Office of Acquisition and Grant Services, on September 15, 2024.
On GovTribe
See Targeted Therapy Technologies, LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors